NCT03015025View on ClinicalTrials.gov

Pharmacogenetic Dosage Algorithm for Acenocoumarol

CompletedOBSERVATIONAL
Enrollment

340

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Atrial FibrillationVenous ThrombosesCardiac Valve Disease
Interventions
GENETIC

Acenocoumarol

A blood sample was collected for CYP2C9, VKORC1, CYP4F2, APOE and 2 variants of POR genotypes.

Trial Locations (1)

28046

Hospital Universitario La Paz, Madrid

All Listed Sponsors
lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT03015025 - Pharmacogenetic Dosage Algorithm for Acenocoumarol | Biotech Hunter | Biotech Hunter